Dr. Tina Yu is a Co-founding Partner of YuanMing Capital, a healthcare fund focusing on cross-border investment strategies. She led the investment in BeiGene, Ascentage Pharma and Mevion Medical Systems, etc.  Dr. Yu has more than fifteen years of professional experience working in the life sciences sector and the financing world of the healthcare industry. Prior to that, Dr. Yu worked for Vision Capital, a NYC-based investment management firm, as a Director of Investment, responsible for US biotech and China sectors. She was a senior research scientist at Wyeth BioPharma, developing therapeutic proteins. She worked for Fidelity, Morgan Stanley and Genzyme. Dr. Yu founded Matching Capital Partners to provide cross-border consulting services in the life sciences industry. Dr. Yu earned her PhD in Chemistry from Princeton University, an MBA from  Harvard Business School. She is a graduate of University of Science and Technology of China with a B.S. in Biology.